In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report), with a price ...

Biogen ( NASDAQ: BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...

Theratechnologies Inc.’s THTX share price has dipped by 14.84%, which has investors questioning if this is right time to buy.

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

Ionis has entered a licence agreement with Sobi in which the latter obtains exclusive rights to commercialise olezarsen.

NewSound, a leading innovator in hearing aids with over two decades of expertise, today launched its first truly AI-driven over-the-counter hearing aid, powered by Femtosense's AI Acceleration.

Garmin Ltd. invites shareholders and investors to listen to its first quarter 2025 earnings conference call on Wednesday, April 30, 2025, at 10:30 a.m. EDT, with executives of Garmin. The call will be ...

Ionis Pharmaceuticals (IONS) announced that it has entered into a license agreement under which Sobi received exclusive rights in countries ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has entered into a license agreement under which Sobi® ...

Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

On Wednesday, 12 March 2025, Ionis Pharmaceuticals (NASDAQ: IONS) presented at the Barclays 27th Annual Global Healthcare Conference. The discussion, led by CFO Beth Hogan, showcased the company’s ...